NCT05978115

Brief Summary

Nine patients selected for this study with mandibular free end saddle and atrophied posterior ridge according to treatment options all patients will be divided randomly into 3 groups:

  • Group A: included three participants who will receive implant retained partial overdentures
  • Group B: included three participants who will receive short implants supported fixed prosthesis
  • Group C: included three participants who will receive long implant supported fixed prosthesis after ridge augmentation.
  • For Group A: Implant retained partial overdenture The implants will be inserted in first premolar areas and partial overdenture will be connected with implant by locator attachment.
  • For Group B: Short implant supported fixed prosthesis The implants will be inserted in first premolar, second premolar, and first molar areas without any ridge augmentation and the implant will be connected by fixed prosthesis
  • For group C: Long implant supported fixed prosthesis after ridge augmentation The implants will be inserted in first premolar, second premolar, and first molar areas with ridge augmentation by using Khoury technique17 and the implants will be connected by fixed prosthesis
  • Clinical evaluation will be made in terms of:
  • Gingival Index (GI)
  • Plaque Index (PI)
  • Pocket Depth (PD)
  • Width of Keratinized Mucosa (KM)
  • Implant Stability (ISQ).
  • Radiographic evaluation will include mandibular residual ridge resorption using the proportional area measurements. evaluation periods will be performed at time of insertion T(0), 6 months after insertion T(6), 12 months after insertion T(6)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 7, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

August 7, 2023

Status Verified

July 1, 2023

Enrollment Period

1.3 years

First QC Date

July 28, 2023

Last Update Submit

July 28, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Gingival Index (GI)

    Modified gingival index will be recorded according to Mombelli et al, as follows: score 0; normal gingival, score 1; mild inflammation (slight change in color \& slight edema), but no bleeding on probing, score 2; moderate inflammation (redness \& edema), and bleeding on probing, and score 3; sever inflammation (marked redness, edema \& ulceration) with tendency to spontaneous bleeding.

    at time of insertion of prosthesis T(0), 6 months after insertion T(6), 12 months after insertion T(12)

  • Plaque Index (PI)

    Plaque will be assessed according to modified plaque index describe by Mombelli et al. as follows: score 0; no plaque detected, score 1; plaque recognized only by running a probe across a smooth marginal surface of the implant, score 2; plaque can be seen by naked eye, and score 3; abundance of soft mater.

    at time of insertion of prosthesis T(0), 6 months after insertion T(6), 12 months after insertion T(12)

  • Pocket Depth (PD)

    Using a calibrated plastic periodontal probe, the distance between marginal border of the gingiva and the tip of the probe will be measured in mm and considered as pocket depth (PD).

    at time of insertion of prosthesis T(0), 6 months after insertion T(6), 12 months after insertion T(12)

  • Width of Keratinized Mucosa (KM)

    The width of peri-implant keratinized mucosa will be measured in mm using a calibrated plastic periodontal probe. Differences in color, texture and mobility between the keratinized mucosa and the lining mucosa served as markers for the detection of the muco-gingival junction. KM was then measured as the distance between the gingival margin and the muco-gingival junction.

    at time of insertion of prosthesis T(0), 6 months after insertion T(6), 12 months after insertion T(12)

  • Implant Stability (ISQ)

    Implant stability will be assessed using resonance frequency analysis (RFA). The resonance frequencies will be measured with the osstell® device (implant stability meter) and expressed with ISQ measurement scale (implant stability quotient).

    at time of insertion of prosthesis T(0), 6 months after insertion T(6), 12 months after insertion T(12)

Study Arms (3)

short implant supported removable partial overdenture

EXPERIMENTAL
Procedure: implant supported prosthesis

short Implant supported fixed partial denture

EXPERIMENTAL
Procedure: implant supported prosthesis

Ridge Augmentation and implant supported fixed partial denture

EXPERIMENTAL
Procedure: implant supported prosthesis

Interventions

Group A: short dental implant placement + Removable partial denture Group B: Short implant placement + Fixed partial denture Group c: Bone Augmentation + Implant placement + Fixed Partial denture

Also known as: Bone augmentation for atrophied ridge
Ridge Augmentation and implant supported fixed partial dentureshort Implant supported fixed partial dentureshort implant supported removable partial overdenture

Eligibility Criteria

Age50 Years - 70 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Atrophied partially edentulism in the posterior mandible having a residual bone height of 6-8mm bone between inferior alveolar nerve and crest of the ridge to receive implants
  • Residual alveolar ridges covered with healthy mucosa without any signs of inflammation or remaining roots.
  • Normal maxilla-mandibular relationship with sufficient available restorative space.

You may not qualify if:

  • Patients with the following conditions will be excluded:
  • Diseases that affect bone metabolism, eg: uncontrolled diabetes, hyperparathyroidism, and osteoporosis.
  • Systemic diseases that may affect osteointegration or complicate surgical procedures, eg: liver diseases, heart diseases and radiotherapy in head and neck region.
  • Abnormal or harmful habits eg: smoking, bruxism, and clenching.
  • Uncooperative patients and patients with poor oral hygiene.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University, Faculty of dentistry

Al Mansurah, Egypt

Location

Related Publications (1)

  • Raffat EM, Shady M, Elkashty AAR, Syad ME. Comparative analysis of implant survival, peri-implant health, and patient satisfaction among three treatment modalities in atrophic posterior mandibles: a randomized clinical study. BMC Oral Health. 2025 Jun 7;25(1):939. doi: 10.1186/s12903-025-06286-7.

MeSH Terms

Interventions

Dental Prosthesis, Implant-Supported

Intervention Hierarchy (Ancestors)

Dental ProsthesisProsthodonticsDentistryProstheses and ImplantsEquipment and Supplies

Study Officials

  • Mohamed Shady, MD

    Mansoura University Faculty of Dentistry, Prosthodontics department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 7, 2023

Study Start

August 20, 2021

Primary Completion

November 20, 2022

Study Completion

February 1, 2024

Last Updated

August 7, 2023

Record last verified: 2023-07

Locations